{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:45:17Z","timestamp":1784940317331,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.xkme.2023.100704","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T21:28:47Z","timestamp":1690838927000},"page":"100704","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis"],"prefix":"10.1016","volume":"5","author":[{"given":"Sylvia E.","family":"Rosas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Ruilope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres Angelo Cadena","family":"Bonfanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Correa-Rotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Francisco Jaramillo","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Pergola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo E.","family":"Umpierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Scalise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlie","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lawatscheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Bakris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xkme.2023.100704_bib1","series-title":"IDF Diabetes Atlas","author":"Magliano DJ. Magliano","year":"2021"},{"issue":"1","key":"10.1016\/j.xkme.2023.100704_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2015-000154","article-title":"Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES 2007\u20132012","volume":"4","author":"Wu","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"9889","key":"10.1016\/j.xkme.2023.100704_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.xkme.2023.100704_bib4","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.ekir.2019.05.012","article-title":"Renal function decline in Latinos with type 2 diabetes","volume":"4","author":"Morales-Alvarez","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.xkme.2023.100704_bib5","series-title":"National diabetes statistics report","year":"2020"},{"issue":"1","key":"10.1016\/j.xkme.2023.100704_bib6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12882-020-01852-3","article-title":"Ethnic minority disparities in progression and mortality of pre-dialysis chronic kidney disease: a systematic scoping review","volume":"21","author":"Hounkpatin","year":"2020","journal-title":"BMC Nephrol"},{"issue":"7","key":"10.1016\/j.xkme.2023.100704_bib7","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1681\/ASN.2010090960","article-title":"Racial and ethnic differences in kidney function decline among persons without chronic kidney disease","volume":"22","author":"Peralta","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.xkme.2023.100704_bib8","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1681\/ASN.2015050570","article-title":"CKD progression and mortality among Hispanics and non-Hispanics","volume":"27","author":"Fischer","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2023.100704_bib9","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.2337\/dc20-0495","article-title":"Sustained lower incidence of diabetes-related end-stage kidney disease among American Indians and Alaska Natives, Blacks, and Hispanics in the U.S., 2000-2016","volume":"43","author":"Burrows","year":"2020","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.xkme.2023.100704_bib10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.oret.2020.07.004","article-title":"Rates of eye care and diabetic eye disease among insured patients with newly diagnosed type 2 diabetes","volume":"5","author":"Gange","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"10.1016\/j.xkme.2023.100704_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001847","article-title":"Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes","volume":"9","author":"An","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"5","key":"10.1016\/j.xkme.2023.100704_bib12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000507047","article-title":"Hospitalization and critical illness in chronic kidney disease","volume":"10","author":"Triozzi","year":"2020","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.xkme.2023.100704_bib13","article-title":"Race\/ethnicity reporting and representation in US clinical trials: a cohort study","volume":"11","author":"Turner","year":"2022","journal-title":"Lancet Reg Health Am"},{"issue":"2","key":"10.1016\/j.xkme.2023.100704_bib15","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","article-title":"Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine","volume":"42","author":"Agarwal","year":"2021","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.xkme.2023.100704_bib16","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.xkme.2023.100704_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000503712","article-title":"Design and baseline characteristics of the Finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial","volume":"50","author":"Ruilope","year":"2019","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2023.100704_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000503713","article-title":"Design and baseline characteristics of the Finerenone in reducing kidney failure and disease progression in diabetic kidney disease trial","volume":"50","author":"Bakris","year":"2019","journal-title":"Am J Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2023.100704_bib19","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"22","key":"10.1016\/j.xkme.2023.100704_bib20","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1002\/sim.8282","article-title":"Mixed-effects models for slope-based endpoints in clinical trials of chronic kidney disease","volume":"38","author":"Vonesh","year":"2019","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.xkme.2023.100704_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11892-022-01454-3","article-title":"Social determinants of health, race, and diabetes population health improvement: Black\/African Americans as a population exemplar","volume":"22","author":"Hill-Briggs","year":"2022","journal-title":"Curr Diab Rep"},{"issue":"4","key":"10.1016\/j.xkme.2023.100704_bib22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1353\/hpu.2010.0630","article-title":"Socioeconomic, cultural, and behavioral factors affecting Hispanic health outcomes","volume":"13","author":"Morales","year":"2002","journal-title":"J\u00a0Health Care Poor Underserved"},{"issue":"9","key":"10.1016\/j.xkme.2023.100704_bib23","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/clc.22732","article-title":"Socioeconomic status and the development of atrial fibrillation in Hispanics, African Americans and non-Hispanic Whites","volume":"40","author":"Shulman","year":"2017","journal-title":"Clin Cardiol"},{"issue":"3","key":"10.1016\/j.xkme.2023.100704_bib24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/jdi.13355","article-title":"Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: estimates from Global Burden of Disease 2017","volume":"12","author":"Li","year":"2021","journal-title":"J\u00a0Diabetes Investig"},{"issue":"5","key":"10.1016\/j.xkme.2023.100704_bib25","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2105\/AJPH.93.5.742","article-title":"Socioeconomic status and dissatisfaction with health care among chronically ill African Americans","volume":"93","author":"Becker","year":"2003","journal-title":"Am J Public Health"},{"issue":"7","key":"10.1016\/j.xkme.2023.100704_bib26","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1007\/s11606-018-4471-1","article-title":"Racial and ethnic disparities in diagnosis of chronic medical conditions in the USA","volume":"33","author":"Kim","year":"2018","journal-title":"J\u00a0Gen Intern Med"},{"issue":"5","key":"10.1016\/j.xkme.2023.100704_bib27","first-page":"351","article-title":"Quality of care for Hispanic adults with diabetes","volume":"39","author":"Mainous","year":"2007","journal-title":"Fam Med"},{"issue":"1","key":"10.1016\/j.xkme.2023.100704_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40615-016-0335-8","article-title":"Racial\/ethnic disparities in diabetes quality of care: the role of healthcare access and socioeconomic status","volume":"5","author":"Canedo","year":"2018","journal-title":"J\u00a0Racial Ethn Health Disparities"},{"issue":"1","key":"10.1016\/j.xkme.2023.100704_bib29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ajhg.2014.11.010","article-title":"The genetic ancestry of African Americans, Latinos, and European Americans across the United States","volume":"96","author":"Bryc","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.xkme.2023.100704_bib30","series-title":"Afro-descendants in Latin America: toward a framework of inclusion","year":"2018"},{"issue":"3","key":"10.1016\/j.xkme.2023.100704_bib31","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1681\/ASN.2016030357","article-title":"African ancestry-specific alleles and kidney disease risk in Hispanics\/Latinos","volume":"28","author":"Kramer","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.xkme.2023.100704_bib32","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.2337\/dc22-0294","article-title":"Finerenone in patients with chronic kidney disease and type 2 diabetes by sodium-glucose cotransporter 2 inhibitor treatment: the FIDELITY analysis","volume":"45","author":"Rossing","year":"2022","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.xkme.2023.100704_bib33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/dom.14883","article-title":"Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use","volume":"25","author":"Rossing","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.xkme.2023.100704_bib40","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.kint.2022.08.040","article-title":"A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes","volume":"103","author":"Bakris","year":"2023","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2023.100704_bib34","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/ki.2011.79","article-title":"An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function","volume":"80","author":"Holtkamp","year":"2011","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.xkme.2023.100704_bib35","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.kint.2020.10.031","article-title":"Characterization and implications of the initial estimated glomerular filtration rate 'dip' upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial","volume":"99","author":"Kraus","year":"2021","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.xkme.2023.100704_bib36","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.kint.2020.10.042","article-title":"Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice","volume":"99","author":"Oshima","year":"2021","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.xkme.2023.100704_bib37","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/0890117120920849","article-title":"Differences in consumption of NASEM priority nutrients and food groups by race\/ethnicity among women living in WIC-participating households","volume":"34","author":"Zimmer","year":"2020","journal-title":"Am J Health Promot"},{"issue":"3","key":"10.1016\/j.xkme.2023.100704_bib39","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jamainternmed.2016.8653","article-title":"Adherence to newly prescribed diabetes medications among insured Latino and White patients with diabetes","volume":"177","author":"Fern\u00e1ndez","year":"2017","journal-title":"JAMA Intern Med"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259005952300122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S259005952300122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T01:25:24Z","timestamp":1762910724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S259005952300122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S259005952300122X"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2023.100704","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2023.100704","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"100704"}}